Skip to content

ONCOLYTICS BIOTECH INC

ONCY

CIK 0001129928 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$28.76M
−26.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.30
0.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$20.12M
Q1 May 2026
Cash
$5.49M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
119.35M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings